Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

Patient-specific 3D-printed titanium implants for facial reconstruction

Official title: Evaluation of the Effectiveness of Patient-Specific 3D-Printed Titanium Facial Implants in the Reconstruction and Aesthetic Correction of Facial Defects: A Clinical Study

Run by Latakia University · NCT07654647 · Data updated 2026-11-12

This study tests whether custom-made 3D-printed titanium facial implants can improve reconstruction and appearance for adults with facial bone defects or asymmetry.

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment30 (estimated)
SponsorLatakia University
Academic / other
Locations1 site (Latakia)
StatusRecruiting
StartedApril 26, 2026
Main results expectedNovember 1, 2026
Study endsNovember 1, 2026
Registry record updatedJune 17, 2026
Trial IDNCT07654647 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years and older with facial bone defects or deformities requiring patient-specific 3D-printed titanium implants for reconstruction or aesthetic augmentation.

Probably not a fit

Patients with active lesions, recent radiotherapy, severe comorbidities, or inability to participate in follow-up may not benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study evaluates the safety and performance of patient-specific titanium implants created with CAD and 3D printing for facial reconstruction. Eligible adults with facial bone defects or deformities will undergo preoperative imaging, implant design, and surgical placement following standard maxillofacial protocols. Postoperative follow-up will measure implant fit, stability, functional outcomes, complications, and patient satisfaction to determine if the approach provides improved symmetry and aesthetics. Outcomes will be assessed through clinical exams and patient-reported measures over a defined observation period.

Why it matters

Potential benefit: If successful, patients may experience improved facial symmetry, better functional outcomes, and higher satisfaction with facial appearance.

How similar studies have gone: Prior work with patient-specific implants and CAD/CAM approaches has shown promise in improving fit and outcomes in facial reconstruction, though this exact 3D-printed titanium strategy is being evaluated for further validation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 years or older.
* Presence of facial bone defects resulting from cystic or tumoral osteolytic lesions.
* Acquired or congenital facial deformities associated with bony defects or facial asymmetry.
* Patients requiring patient-specific 3D-printed titanium implants for maxillofacial reconstruction.
* Aesthetic indications requiring custom facial implant design, including microgenia (chin retrusion).
* Ability to provide written informed consent.

Exclusion Criteria:

* Active pathological lesions at the time of enrollment.
* Age below 18 years.
* History of radiotherapy within 12 months prior to enrollment.
* Chronic untreated vitamin D deficiency.
* Uncontrolled diabetes mellitus.
* Inability or unwillingness to comply with follow-up requirements.

Where it's running

  • Ahmad Fayez Ahmad
    Latakia, Syria
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.